WallStSmart

POMDOCTOR LIMITED American Depositary Shares (POM)vsWellgistics Health, Inc. Common Stock (WGRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

POMDOCTOR LIMITED American Depositary Shares generates 2750% more annual revenue ($399.92M vs $14.03M). WGRX leads profitability with a 0.0% profit margin vs -53.2%. WGRX earns a higher WallStSmart Score of 30/100 (F).

POM

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 4/9

WGRX

Avoid

30

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -14.20

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

POM1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
17.2%8/10

17.2% revenue growth

WGRX1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.9110/10

Conservative balance sheet, low leverage

Areas to Watch

POM4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$14.51M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-149.49M2/10

Negative free cash flow — burning cash

WGRX4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$9.35M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : POM

The strongest argument for POM centers on Revenue Growth. Revenue growth of 17.2% demonstrates continued momentum.

Bull Case : WGRX

The strongest argument for WGRX centers on Debt/Equity.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Bear Case : WGRX

The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

POM profiles as a growth stock while WGRX is a value play — different risk/reward profiles.

POM is growing revenue faster at 17.2% — sustainability is the question.

WGRX generates stronger free cash flow (-4M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WGRX scores higher overall (30/100 vs 28/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Wellgistics Health, Inc. Common Stock

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.

Want to dig deeper into these stocks?